Upperton to Attend DCAT Week in New York, 16-19 March

Upperton will attend DCAT Week 2025, Nikki Whitfield, CEO, and Ian Lafferty, CTO, will represent Upperton during the event.
Interactive Sterile Brochure
Home / Resources Our Interactive Sterile Brochure. Explore our expertise. Speak to our experts We’re here to help. Interested in learning more about our CDMO capabilities and expertise? Speak to our team to discuss your requirements.
Interactive Brochure
Home / Resources Our Interactive Capacity Brochure. Explore our expertise. Speak to our experts We’re here to help. Interested in learning more about our CDMO capabilities and expertise? Speak to our team to discuss your requirements.
Upperton wins Pharma Project of the Year at the Pharma Industry Awards UK 2024

Upperton wins Pharma Project of the Year at the Pharma Industry Awards UK 2024.
Upperton Pharma Solutions Adds Large-Scale Processing following MHRA Approval at Nottingham Facility

Upperton Pharma Solutions Adds Large-Scale Processing following MHRA Approval at Nottingham Facility, Trent Gateway.
Upperton wins Outstanding Achievement at Medilink UK National Healthcare Business Awards 2024

Upperton win’s Outstanding Achievement at Medilink UK National Healthcare Business Awards 2024 for Trent Gateway facility build.
Upperton Recognised in Sunday Times 100 Fastest-Growing Companies 2024

We’re honoured to announce that Upperton has been recognised as one of the Sunday Times’ 100 fastest-growing companies in the UK for 2024.
Upperton Joined by Professor Dame Sarah Gilbert, To Officially Open New Development and GMP Manufacturing Facility.

Upperton Joined by Professor Dame Sarah Gilbert, To Officially Open New Development and GMP Manufacturing Facility.
Upperton Strengthens Capabilities with Installation of Gerteis Roller Compactor

Upperton strengthens capabilities with installation of Gerteis roller compactor at Nottingham gmp manufacturing facility.
Upperton announces expansion into sterile drug manufacturing with new £5million GMP facility

Upperton Pharma Solutions has announced a £5million investment to expand operations into small-scale sterile fill-finish.